LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Clinical spectrum and gene mutations in a Chinese cohort with anoctaminopathy

Photo by nci from unsplash

Recessive mutations in anoctamin-5 (ANO5) are responsible for limb-girdle muscular dystrophy (LGMD) 2 L and non-dysferlin Miyoshi-like distal myopathy. ANO5 mutations are prevalent in European countries, however it is not common… Click to show full abstract

Recessive mutations in anoctamin-5 (ANO5) are responsible for limb-girdle muscular dystrophy (LGMD) 2 L and non-dysferlin Miyoshi-like distal myopathy. ANO5 mutations are prevalent in European countries, however it is not common in patients of Asian origin and there is no data regarding Chinese population. We retrospectively reviewed the clinical manifestations and gene mutations of patients with Anoctaminopathy. A total of 5 ANO5 mutations including 4 novel mutations and one reported mutation in four patients from three families. Three patients presented presymptomatic hyperCKemia and one patient had limb muscle weakness. Muscle imaging of lower limbs showed preferential adductor magnus and medial gastrocnemius involvement. No hotspot was identified in Chinese patients to date.

Keywords: gene mutations; chinese cohort; spectrum gene; mutations chinese; clinical spectrum; gene

Journal Title: Neuromuscular Disorders
Year Published: 2019

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.